Dooley, Kelly E <br/><br/>
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  2015 
 - 3399-405 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05128-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antitubercular Agents--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Male<br/>Middle Aged<br/>Rifampin--administration & dosage<br/>Young Adult